ArticleFrontiers in pediatrics2023

Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment.

Yuri Murayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.